Search research articles
Contact Us
Filters
Showing results (331-340 of 373) with videos related to
Page
of 38
Sort By:
Frontiers in Oncology
|
July 5, 2022
Clinicopathological Characteristics and Prognosis of HER2-Low Early-Stage Breast Cancer: A Single-Institution Experience
Hangcheng Xu, Yiqun Han, Yun Wu, et al.
Nature Immunology
|
December 7, 2010
Control of the differentiation of regulatory T cells and T(H)17 cells by the DNA-binding inhibitor Id3
Takashi Maruyama, Jun Li, Jose P Vaque, et al.
The Journal of Comparative Neurology
|
April 15, 2016
Running exercise protects the capillaries in white matter in a rat model of depression
Lin-Mu Chen, Ai-Pin Zhang, Fei-Fei Wang, et al.
Cancer Chemotherapy and Pharmacology
|
September 17, 2010
Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice
Zhen-Qian Wu, Xiao-Dong Han, Yu Wang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 24, 2016
Serum stearic acid/palmitic acid ratio as a potential predictor of diabetes remission after Roux-en-Y gastric bypass in obesity
Linjing Zhao, Yan Ni, Haoyong Yu, et al.
Journal of the National Cancer Center
|
July 22, 2024
Docetaxel plus S-1 versus docetaxel plus capecitabine as first-line treatment for advanced breast cancer patients: a prospective randomized phase II study
Nilupai Abudureheiyimu, Yun Wu, Qing Li, et al.
BMJ Open
|
January 20, 2025
Association of quality of life in older patients with breast cancer: a cross-sectional study from China
Min Xiao, Lei Ji, Xiaoyan Qian, et al.
International Journal of Cancer
|
June 27, 2020
Platinum-based chemotherapy in advanced triple-negative breast cancer: A multicenter real-world study in China
Yimeng Chen, Yin Guan, Jiayu Wang, et al.
Breast (Edinburgh, Scotland)
|
April 9, 2025
The ideal strategies of antibody‒drug conjugate sequential treatment in HER2-expressing metastatic breast cancer: A multi-center real-world study
Xuenan Peng, Bo Lan, Jiayu Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 13, 2017
Phase I Study and Biomarker Analysis of Pyrotinib, a Novel Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer
Fei Ma, Qiao Li, Shanshan Chen, et al.
Page
of 38
Search research articles
Search
Showing results (331-340 of 373) with videos related to
Sort By:
Page
of 38
Frontiers in Oncology
|
July 5, 2022
Clinicopathological Characteristics and Prognosis of HER2-Low Early-Stage Breast Cancer: A Single-Institution Experience
Hangcheng Xu, Yiqun Han, Yun Wu, et al.
Nature Immunology
|
December 7, 2010
Control of the differentiation of regulatory T cells and T(H)17 cells by the DNA-binding inhibitor Id3
Takashi Maruyama, Jun Li, Jose P Vaque, et al.
The Journal of Comparative Neurology
|
April 15, 2016
Running exercise protects the capillaries in white matter in a rat model of depression
Lin-Mu Chen, Ai-Pin Zhang, Fei-Fei Wang, et al.
Cancer Chemotherapy and Pharmacology
|
September 17, 2010
Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice
Zhen-Qian Wu, Xiao-Dong Han, Yu Wang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 24, 2016
Serum stearic acid/palmitic acid ratio as a potential predictor of diabetes remission after Roux-en-Y gastric bypass in obesity
Linjing Zhao, Yan Ni, Haoyong Yu, et al.
Journal of the National Cancer Center
|
July 22, 2024
Docetaxel plus S-1 versus docetaxel plus capecitabine as first-line treatment for advanced breast cancer patients: a prospective randomized phase II study
Nilupai Abudureheiyimu, Yun Wu, Qing Li, et al.
BMJ Open
|
January 20, 2025
Association of quality of life in older patients with breast cancer: a cross-sectional study from China
Min Xiao, Lei Ji, Xiaoyan Qian, et al.
International Journal of Cancer
|
June 27, 2020
Platinum-based chemotherapy in advanced triple-negative breast cancer: A multicenter real-world study in China
Yimeng Chen, Yin Guan, Jiayu Wang, et al.
Breast (Edinburgh, Scotland)
|
April 9, 2025
The ideal strategies of antibody‒drug conjugate sequential treatment in HER2-expressing metastatic breast cancer: A multi-center real-world study
Xuenan Peng, Bo Lan, Jiayu Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 13, 2017
Phase I Study and Biomarker Analysis of Pyrotinib, a Novel Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer
Fei Ma, Qiao Li, Shanshan Chen, et al.
Page
of 38